Fundraising Fox
Kimihito Usui
InvestorSenior Principal at Axil Capital · Deputy General Counsel at Altamont Capital Partners
Japan
Writes $100K – $5M checks · typically $1.5M
Find your path to Kimihito
Sign up to see every warm intro you have to Kimihito
- Paths you didn't know you had: your email and LinkedIn already hold routes to Kimihito. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Kimihito Usui is a Senior Principal at Axil Capital Partners (Axil Capital Advisors K.K.), focusing on early-stage biotech investment across the US, Japan, and Taiwan. He holds a Ph.D. in pharmaceutical sciences from the University of Tokyo and worked as a researcher on artificial cell models and later as a lead researcher at a drug discovery venture, where he handled preclinical study design, budget management, fundraising, and business development, publishing 12 peer-reviewed papers. Since 2016 he has worked in life science and healthcare investment, establishing his firm's first direct biotech investment scheme in a securities-based principal investment division and completing direct investments in nine companies across the US and Japan, two of which listed on NASDAQ.
Colleagues at Axil Capital
Frequently asked questions
- Who is Kimihito Usui?
- Kimihito Usui is a Senior Principal at Axil Capital Partners (Axil Capital Advisors K.K.), focusing on early-stage biotech investment across the US, Japan, and Taiwan. He holds a Ph.D. in pharmaceutical sciences from the University of Tokyo and worked as a researcher on artificial cell models and later as a lead researcher at a drug discovery venture, where he handled preclinical study design, budget management, fundraising, and business development, publishing 12 peer-reviewed papers. Since 2016 he has worked in life science and healthcare investment, establishing his firm's first direct biotech investment scheme in a securities-based principal investment division and completing direct investments in nine companies across the US and Japan, two of which listed on NASDAQ.
- Where does Kimihito Usui work?
- Kimihito Usui is Senior Principal at Axil Capital and Deputy General Counsel at Altamont Capital Partners.
- What check size does Kimihito Usui write?
- Kimihito Usui typically writes checks of $100K – $5M.
About this profile. Compiled from public sources — Axil Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights